References
1
Krow GR.
Org. React.
1993,
43:
251
2
Walsh CT.
Chen Y.-CJ.
Angew. Chem.
1988,
100:
342
3
Willetts A.
Trends Biotechnol.
1997,
15:
55
4
Roberts SM.
J. Mol. Catal. B: Enzym.
1998,
4:
111
5
Stewart JD.
Curr. Org. Chem.
1998,
2:
195
6a
Kelly DR.
Chim. Oggi
2000,
18:
33
6b
Kelly DR.
Chim. Oggi
2000,
18:
52
7
Bolm C.
Schlingloff G.
Weickhardt K.
Angew. Chem., Int. Ed. Engl.
1994,
33:
1848
8
Gusso A.
Baccin C.
Pinna F.
Strukul G.
Organometallics
1994,
13:
3442
9
Bolm C.
Schlingloff G.
J. Chem. Soc., Chem. Commun.
1995,
1247
10
Bolm C.
Schlingloff G.
Bienewald F.
J. Mol. Catal. A: Chemical
1997,
117:
347
11
Bolm C.
Luong TKK.
Schlingloff G.
Synlett
1998,
1151
12
Strukul G.
Varagnolo A.
Pinna F.
J. Mol. Catal. A: Chemical
1997,
117:
413
13
Bolm C.
Beckmann O.
Kühn T.
Palazzi C.
Adam W.
Rao PB.
Saha-Möller CR.
Tetrahedron: Asymmetry
2001,
12:
2441
14
Uchida T.
Katsuki T.
Tetrahedron Lett.
2001,
42:
6911
15
Vogel M.
Scharz-Linek U.
Bioorg. Chem.
1999,
102
16
Schwarz-Linek U.
Krödel A.
Ludwig F.-A.
Schulze A.
Rissom S.
Kragl U.
Tishkov VI.
Vogel M.
Synthesis
2001,
947
17
Donoghue NA.
Norris DB.
Trudgill PW.
Eur. J. Biochem.
1976,
63:
175
18
Kayser M.
Chen G.
Stewart J.
Synlett
1999,
153
19
Chen G.
Kayser MM.
Mihovilovic MD.
Mrstik ME.
Martinez CA.
Stewart JD.
New J. Chem.
1999,
23:
827
20
Griffin M.
Trudgill PW.
Biochem. J.
1972,
129:
595
21
Griffin M.
Trudgill PW.
Eur. J. Biochem.
1976,
63:
199
22
Trudgill PW.
Methods Enzymol.
1990,
188:
77
23
Bes MT.
Villa R.
Roberts SM.
Wan PWH.
Willetts AJ.
J. Mol. Catal. B: Enzym.
1996,
1:
127
24
Adger B.
Bes MT.
Grogan G.
McCague R.
Pedragosa-Moreau S.
Roberts SM.
Villa R.
Wan PWH.
Willetts AJ.
Bioorg. Med. Chem.
1997,
5:
253
25 Iwaki, H.; Hasegawa, Y.; Lau, P. C. K.; Wang, S.; Kayser, M. M. submitted to Appl. Environ. Microbiol.
26
Mihovilovic MD.
Chen G.
Wang S.
Kyte B.
Rochon F.
Kayser MM.
Stewart JD.
J. Org. Chem.
2001,
66:
733
27
Mihovilovic MD.
Müller B.
Kayser MM.
Stewart JD.
Fröhlich J.
Stanetty P.
Spreitzer H.
J. Mol. Catal. B: Enzym.
2001,
11:
349
28 For an alternative E. coli expression system for CHMO see: Doig SD.
O’Sullivan LM.
Patel S.
Ward JM.
Woodley JM.
Enzyme Microb. Technol.
2001,
28:
265
29 Application of the above system for whole-cell biotransformations: Simpson HD.
Alphand V.
Furstoss R.
J. Mol. Catal. B: Enzym.
2001,
16:
101
30
Riva R.
Banfi L.
Danieli B.
Guanti G.
Lesma G.
Palmisano G.
J. Chem. Soc., Chem. Commun.
1987,
299
31
Hieble JP.
Nichols AJ.
Langer SZ.
Ruffolo RR. In
Principles of Pharmacology
Munson PL.
Chapman and Hall;
New York:
1996.
p.135
32
Szántay C.
Honzy K.
Chem. Heterocycl. Compd.
1994,
25 (Suppl.):
161
33
Danieli B.
Lesma G.
Mauro M.
Palmisano G.
Passerella D.
Tetrahedron
1994,
50:
8837
34
Johns SR.
Lamberton JA.
Occolowitz JL.
J. Chem. Soc., Chem. Commun.
1967,
229
35
Krawczyk AR.
Jones JB.
J. Org. Chem.
1989,
54:
1795
36
Mundy BP.
Theodore JJ.
J. Am. Chem. Soc.
1980,
102:
2005
37
Aube J.
Gosh S.
Tanol M.
J. Am. Chem. Soc.
1994,
116:
9009
38
Barret AGM.
Boys ML.
Boehm TL.
J. Org. Chem.
1996,
61:
685
39
Bar R.
Trends Biotechnol.
1989,
7:
2
40
Miyafuji A.
Ito K.
Katsuki T.
Heterocycles
2000,
52:
261
41 Physical and spectroscopic data of lactones 2:
(4a
R
,8a
R
)-1,4,4a,5,8,8a-Hexahydro-3
H
-2-benzopyran-3-one(2a). Colorless oil; [α]D
20 = +24.5 (c 1.0, CHCl3); ee >99% (chiral phase GC); 1H NMR (200 MHz, CDCl3): δ = 1.80-2.13 (m, 2 H), 2.16-2.44 (m, 4 H), 2.50-2.60 (m, 2 H), 4.22-4.40 (m, 2 H), 5.67 (br s, 2 H); 13C NMR (50 MHz, CDCl3): δ = 24.0 (t), 28.4 (t), 28.5 (d), 29.6 (d), 33.7 (t), 72.1 (t), 124.1 (d), 124.6 (d), 170.6 (s).
(4a
R
,8a
R
)
-
Octahydro-3
H
-2-benzopyran-3-one(2b). Colorless oil; [α]D
20 = +39.1 (c 1.0, CHCl3); ee = 99% (chiral phase GC); 1H NMR (200 MHz, CDCl3): δ = 1.22-1.63 (m, 8 H), 1.83-2.01 (m, 1 H), 2.05-2.25 (m, 1 H), 2.40-2.55 (m, 2 H), 4.25 (d, 2 H, J = 8 Hz); 13C NMR (50 MHz, CDCl3): δ = 21.5 (t), 23.3 (t), 24.6 (t), 28.6 (t), 31.0 (d), 32.7 (d), 32.8 (t), 72.4 (t), 171.1 (s).
